Showing results (181-190 of 241) with videos related to
Sort By:
Pageof 25
Neurology|November 27, 2002
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findingsS Furtado, M Farrer, Y Tsuboi, et al.Allergy|May 26, 2017
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysisS Dhami, A Kakourou, F Asamoah, et al.Allergy|October 9, 2016
European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessmentM A Calderón, C Vidal, P Rodríguez Del Río, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 16, 2007
Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 yearsRichard W Hertle, Mitchell M Scheiman, Roy W Beck, et al.Rhinology|July 20, 2019
ARIA masterclass 2018: From guidelines to real-life implementationP W Hellings, S F Seys, G Marien, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|June 23, 2009
Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trialsMichael X Repka, Raymond T Kraker, Roy W Beck, et al.HNO|December 29, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]L Klimek, S Becker, B Haxel, et al.HNO|April 8, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]L Klimek, S Becker, B Haxel, et al.HNO|February 3, 2026
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI]L Klimek, S Becker, B Haxel, et al.Rhinology|July 7, 2025
Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in GermanyF Bärhold, J Hagemann, L Klimek, et al.Pageof 25